Mathematical models for absorption and efficacy of ovarian cancer treatments

2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2014

Volumn , Issue , 2014, Pages 3442-3445

  Zou, Jianmin ^a   Gundry, Stephen ^a   Ganic, Emir ^b   Üyar, M Umit ^a  

^a City College of New York   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION SUPPORT SYSTEMS;

BEVACIZUMAB; CARBOPLATIN; CLINICAL DECISION SUPPORT; DOCETAXEL; OVARIAN CANCERS; PACLITAXEL; PRE-CLINICAL; RESEARCH EFFORTS;

DISEASES;

ANTINEOPLASTIC AGENT;

ABSORPTION; ANIMAL; BIOLOGICAL MODEL; COMPUTER INTERFACE; COMPUTER PROGRAM; COMPUTER SIMULATION; DECISION SUPPORT SYSTEM; DISEASE MODEL; FEMALE; HUMAN; MOUSE; OVARIAN NEOPLASMS; TREATMENT OUTCOME;

ABSORPTION, PHYSIOLOGICAL; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMPUTER SIMULATION; DECISION SUPPORT SYSTEMS, CLINICAL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MODELS, BIOLOGICAL; OVARIAN NEOPLASMS; SOFTWARE; TREATMENT OUTCOME; USER-COMPUTER INTERFACE;

EID: 84927548495     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/EMBC.2014.6944363     Document Type: Conference Paper

References (12)

1. J. Harrold, R. Parker, Clinically relevant cancer chemotherapy dose scheduling via mixed-integer optimization, Computers & Chemical Engineering 33 (12) (2009) 2042-2054.
2. Clinical practice guidelines in oncology: Ovarian cancer, National Comprehensive Cancer Network, http://www.nccn.org.
3. P. Magni, M. Simeoni, I. Poggesi, et al., A mathematical model to study the effects of drugs administration on tumor growth dynamics, Mathematical Biosciences 200 (2) (2006) 127-151.
4. P. H. Van Der Graaf, J. Gabrielsson, Pharmacokinetic-pharmacodynamic reasoning in drug discovery and early development, Future Medicinal Chemistry 1 (8) (2009) 1371-1374.
5. E. Ganic, S. Gundry, J. Zou, M. U. Uyar, Evaluation of anti-cancer therapy using in silico analysis of treatments for HER2+ breast cancer, in: IEEE Intl. Symposium on Medical Measurements and Applications (MeMeA 2014), Lisbon, portugal, June, 2014.
6. S. Gundry, J. Zou, E. Urrea, C. Sahin, J. Kusyk, M. Uyar, Analysis of emergent behavior for ga-based topology control mechanism for self-spreading nodes in MANETs, in: Advances in Intelligent Modelling and Simulation, Vol. 422 of Studies in Computational Intelligence, Springer Berlin Heidelberg. 2012, pp. 155-183.
7. C. S. Sahin, S. Gundry, M. U. Uyar, Markov chain analysis of self-organizing mobile nodes, Journal of Intelligent and Robotic Systems 67 (2012) 133-153.
8. J. Kusyk, C. Sahin, M. Uyar, E. Urrea, S. Gundry, Self organization of nodes in mobile ad hoc networks using evolutionary games and genetic algorithms, Journal of Advanced Research (2011) 253-264.
9. M. Rocchetti, M. Simeoni, E. Pesenti, et al., Predicting the active doses in humans from animal studies: A novel approach in oncology, European Journal of Cancer 43 (12) (2007) 1862-1868.
10. D. K. Shah, J. Veith, R. J. Bernacki, J. P. Balthasar, Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancer, Cancer chemotherapy and pharmacology 68 (4) (2011) 951-958.
11. H. Wang, M. Li, J. J. Rinehart, R. Zhang, Pretreatment with dexam-ethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy, Clinical cancer research 10 (5) (2004) 1633-1644.
12. M. Simeoni, P. Magni, C. Cammia, et al., Predictive pharmacokinetic pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents, Cancer Research 64 (2004) 1094-1101.